Thoracic Oncology

 Sunvozertinib

Shelby Quinn's profile image
Shelby Quinn posted 09-23-2025 02:30 PM

Does anyone have a contact at Dizal Pharmaceuticals or been successful in contacting them about sunvozertinib? 

Stefanie Houseknecht's profile image
Stefanie Houseknecht

Yes, on 8/19/25 we were given the following information from the individual whose contact information I am copying below. I apologize that it is likely not the response you wanted to hear (it certainly is not what we were hoping to hear):

At the moment, the drug will not be available for another 3 months as things are still being set up. I don’t have any new details to share just yet, but I will keep you posted on any updates as they become available. I really appreciate your patience and understanding.

With best regards,

Sadashiva Swamy

Sr. Global Study Leader

T: + 86 21 6109 5842

Amanda Cass's profile image
Amanda Cass

Our specialty pharmacy had initially been in contact with someone who said it would be available Q4 of this year but have since found out it likely won't be until 2026 sometime

Kevin Chen's profile image
Kevin Chen SIG Leader

Hi all - was curious if anyone's heard any recent updates regarding sunvozertinib access or have been successful in getting it at their institution?

Best,

-kevin

Stefanie Houseknecht's profile image
Stefanie Houseknecht

Hi Kevin,

I saw your message yesterday and I emailed the contact I have at Dizal.

This was the exact response I received this morning (see below). Frustrating, I know!

Dear Stefanie,

We appreciate your follow-up. Right now, we are actively working to establish the necessary infrastructure and processes to make the drug available through appropriate channels. While we do not yet have specific timelines or details to share, this remains a high priority for our team, and we are committed to keeping you informed as progress is made. We sincerely appreciate your patience and understanding as we navigate this transition.

With best regards,

Sadashiva Swamy

Sr. Global Study Leader

T: + 86 21 6109 5842